Hoxworth celebrates Black History Month
As Hoxworth Blood Center, University of Cincinnati celebrates Black History Month, it is essential to recognize and pay tribute to the remarkable contributions of African American physicians who have played pivotal roles in advancing the field of hematology. From groundbreaking research on sickle cell anemia to transformative work in blood banking, these trailblazers have not only shaped the course of medical history but have also left an indelible mark on the lives of countless individuals.
Dr. Charles Drew
Dr. Charles Drew: The father of blood banking
In the 1940s, Dr. Charles Drew made groundbreaking contributions to hematology, earning him the title "Father of Blood Banking." His research demonstrated the feasibility of drying and reconstituting plasma, leading to the establishment of the first centralized locations for blood collections during World War II. Drew's work laid the foundation for standardized blood processing and preservation, benefiting countless lives.
Dr. Louis Sullivan
Dr. Louis Sullivan: Advocacy, education, and diversity in medicine
Dr. Louis Sullivan, a passionate advocate for minority health issues, founded the Morehouse School of Medicine in 1975 to address the underrepresentation of African Americans in the physician workforce. Serving as the Secretary of the Department of Health and Human Services in 1989, Sullivan played a pivotal role in promoting gender and ethnic diversity in senior positions throughout DHHS, leaving a lasting impact on healthcare leadership and minority representation in medicine.
Dr. James Bowman
Dr. James Bowman: Ethical considerations and comprehensive care
Dr. James Bowman, father of President Barack Obama's Senior Advisor Valerie Jarrett, made significant contributions to the ethical aspects of sickle cell screening. His research underscored the importance of ethical considerations, education, and the potential harms associated with screening programs. Bowman played a crucial role in the establishment of Comprehensive Sickle Cell Centers in the 1970s, emphasizing a holistic approach to care. Additionally, his work extended to advancements in therapeutic procedures, including the incorporation of apheresis techniques, further enhancing the comprehensive care provided to individuals with sickle cell disease.
Dr. Yvette Francis-McBarnette
Dr. Yvette Francis-McBarnette: Breaking barriers and innovating care
A true trailblazer, Dr. Yvette Francis-McBarnette broke barriers for both women and African Americans in medicine. As the second black female student to enroll in the Yale School of Medicine in 1946, she paved the way for future generations. Francis-McBarnette's contributions extended to the medical management of Sickle Cell Disease, where she implemented the use of prophylactic antibiotics in children with Sickle Cell Disease, anticipating their effectiveness well before confirmation in medical literature. Yvette helped patients like our local recipients, DeShawna Williams, and Carla Howard.
As we reflect on their achievements, including the collaborative efforts with Hoxworth and Cincinnati, we acknowledge the invaluable legacy they have bestowed upon the world of medicine. Their pioneering work serves as a beacon, guiding us in our ongoing commitment to furthering medical knowledge, promoting ethical standards, and fostering inclusivity in healthcare. The stories of these trailblazers continue to inspire and pave the way for a future where healthcare is not only advanced but also accessible and equitable for all.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.